The Neuro (Montreal Neurological Institute-Hospital) is proud to celebrate the election of three of its distinguished researchers to the Canadian Academy of Health Sciences (CAHS): Dr. Edward Fon, Director of The Neuro, Professor Michael Petrides, and Professor Robert Zatorre.
The Info-Neuro resources cart schedule for August is as follows:
Here are our 6 book recommendations to add to your summer reading list!
Six great reads for the season, whether you’re looking for strategies to tackle stress, how to improve your sleeping habits, nutrition and wellness tips, and more.
The bigger, the better!
The Info-Neuro resources cart schedule for July is as follows:
Today is National Indigenous Peoples Day—a time to recognize and celebrate the traditions, cultures, and contributions of First Nations, Inuit and Métis.
We encourage you to take some time to learn more about First Nations, Inuit and Métis as well as our collective past. The best way to do this is through their own voices. We’ve selected books by Indigenous authors from our book collection on Indigenous health.
Stop by in person at Room 354 (3rd floor) at the Neuro (Montreal Neurological Institute-Hospital) to borrow our physical books.
Celebrate Pride Month with MUHC Libraries and Patient Resource Centers!
In honour of Pride Month, MUHC libraries and patient resource centers are highlighting their resources on 2SLGBTQI+ health and wellness.
If you would like to explore topics such as identity, family life, relationships and mental health, you are sure to find something of interest!
“Letters to ALS: Our Journeys to Hope” is a new book that brings together inspiring and touching stories from people living with ALS, their loved ones, healthcare professionals, and researchers, including members of The Neuro community.
You can pick up a free copy of the book in person at the Neuro Patient Resource Centre, located on the 3rd floor, Room 354.
An innovative project led by Dr. Guy Rouleau at The Neuro has received major funding from Brain Canada, one of four platforms that are advancing treatment discovery across a wide range of neurological disorders. In total the four platforms are being supported with a $8,926,500 investment.
A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test could one day identify people at high risk of MS in time to act before damage occurs.
Five researchers from The Neuro (Montreal Neurological Institute-Hospital) are leading innovative new projects that have received major funding from Canada Foundation for Innovation’s Innovation Fund. They will be funded for a total of $14.5 million, part of $42 million going to McGill University scientists.
Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.
An initiative to reduce wait times for spinal cord surgery, research that is testing ways to inhibit brain cancer cells, an open database for multiple sclerosis and an app that tracks Alzheimer’s progression and aids diagnosis. All these projects and more were made possible by a campaign that has raised $203.9 million for groundbreaking neuroscience research and patient care.
A diagnosis is often a cue for people to change the way they live. For people diagnosed with cardiovascular conditions such as heart disease or diabetes, it is often a motivator to get more physical exercise, which can improve long-term health. However, the rate of physical activity increase after diagnosis varies widely depending on the individual.
A surgical device powered by artificial intelligence (AI) was demonstrated live for the first time at The Neuro (Montreal Neurological Institute-Hospital) in a historic step forward for the field of precision neurosurgery. SENTRY™, an innovative technology developed by Montreal-based Reveal and its university partners, can differentiate cancerous tissue from healthy tissue in real time, offering tangible hope to patients for better outcomes.
